Related references
Note: Only part of the references are listed.Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study
Christopher J. Child et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Long-Term Safety of Growth Hormone Replacement after CNS Irradiation
S. Mackenzie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Growth hormone, the insulin-like growth factor axis, insulin and cancer risk
Peter E. Clayton et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Serum Insulin-Like Growth Factor I (IGF-I), IGF-Binding Proteins 2 and 3, and the Risk for Development of Malignancies in Adults with Growth Hormone (GH) Deficiency Treated with GH: Data from KIMS (Pfizer International Metabolic Database)
Vera Popovic et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Growth Hormone Treatment in Children is not Associated with an Increase in the Incidence of Cancer: Experience from KIGS (Pfizer International Growth Database)
Patrick Wilton et al.
JOURNAL OF PEDIATRICS (2010)
Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies
Timothy J. Key et al.
LANCET ONCOLOGY (2010)
Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: A systematic review
Renee L. Mulder et al.
CANCER TREATMENT REVIEWS (2009)
Changing Patterns of the Adult Growth Hormone Deficiency Diagnosis Documented in a Decade-Long Global Surveillance Database
Susan M. Webb et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Insulin-like growth factors, their binding proteins, and prostate cancer risk:: Analysis of individual patient data from 12 prospective studies
Andrew W. Roddam et al.
ANNALS OF INTERNAL MEDICINE (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia
Nobuko Hijiya et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
The role of the IGF system in cancer growth and metastasis: Overview and recent insights
Amir Abbas Samani et al.
ENDOCRINE REVIEWS (2007)
Long-term effects of treatments for childhood cancers
Jorge A. Alvarez et al.
CURRENT OPINION IN PEDIATRICS (2007)
New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the childhood cancer survivor study
Joseph P. Neglia et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia
James G. Gurney et al.
CANCER (2006)
Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor
Berrin Ergun-Longmire et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement
TT Chung et al.
CLINICAL ENDOCRINOLOGY (2005)
Adult growth hormone replacement therapy and neuroimaging surveillance in brain tumour survivors
A Jostel et al.
CLINICAL ENDOCRINOLOGY (2005)
Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy
J Svensson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Second neoplasms after treatment of childhood cancer in Slovenia
L Jazbec et al.
PEDIATRIC BLOOD & CANCER (2004)
Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study
AJ Swerdlow et al.
LANCET (2002)
Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: A report from the childhood cancer survivor study
CA Sklar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Growth hormone treatment of children with brain tumors and risk of tumor recurrence
AJ Swerdlow et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Share Paper
